Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy J Johnson

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Cancer Research|April 3, 2004
Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targetsLaura J Rush, Aparna Raval, Pauline Funchain, et al.
The AAPS Journal|September 8, 2012
Pharmacokinetics and tissue disposition of lenalidomide in miceDarlene M Rozewski, Sarah E M Herman, William H Towns, et al.
Blood Advances|January 4, 2018
Novel <i>SF3B1</i> in-frame deletions result in aberrant RNA splicing in CLL patientsAnant A Agrawal, Michael Seiler, Lindsey T Brinton, et al.
Leukemia & Lymphoma|March 2, 2019
Modulation of immune checkpoint molecule expression in mantle cell lymphomaBonnie K Harrington, Esther Wheeler, Kasey Hornbuckle, et al.
JCI Insight|August 9, 2021
Optimizing extracellular vesicles' isolation from chronic lymphocytic leukemia patient plasma and cell line supernatantSara Elgamal, Emanuele Cocucci, Ellen J Sass, et al.
Blood|January 15, 2008
Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calciumSyed-Rehan A Hussain, David M Lucas, Amy J Johnson, et al.
Blood|July 19, 2018
Noncovalent inhibition of C481S Bruton tyrosine kinase by GDC-0853: a new treatment strategy for ibrutinib-resistant CLLSean D Reiff, Elizabeth M Muhowski, Daphne Guinn, et al.
Leukemia Research|August 2, 2014
A dose escalation feasibility study of lenalidomide for treatment of symptomatic, relapsed chronic lymphocytic leukemiaKami Maddocks, Amy S Ruppert, Rebekah Browning, et al.
Plos One|November 13, 2010
Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol dispositionWenjun Ni, Jia Ji, Zunyan Dai, et al.
Blood|March 31, 2010
17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibitionErin Hertlein, Amy J Wagner, Jeffrey Jones, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Cancer Research|April 3, 2004
Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targetsLaura J Rush, Aparna Raval, Pauline Funchain, et al.
The AAPS Journal|September 8, 2012
Pharmacokinetics and tissue disposition of lenalidomide in miceDarlene M Rozewski, Sarah E M Herman, William H Towns, et al.
Blood Advances|January 4, 2018
Novel <i>SF3B1</i> in-frame deletions result in aberrant RNA splicing in CLL patientsAnant A Agrawal, Michael Seiler, Lindsey T Brinton, et al.
Leukemia & Lymphoma|March 2, 2019
Modulation of immune checkpoint molecule expression in mantle cell lymphomaBonnie K Harrington, Esther Wheeler, Kasey Hornbuckle, et al.
JCI Insight|August 9, 2021
Optimizing extracellular vesicles' isolation from chronic lymphocytic leukemia patient plasma and cell line supernatantSara Elgamal, Emanuele Cocucci, Ellen J Sass, et al.
Blood|January 15, 2008
Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calciumSyed-Rehan A Hussain, David M Lucas, Amy J Johnson, et al.
Blood|July 19, 2018
Noncovalent inhibition of C481S Bruton tyrosine kinase by GDC-0853: a new treatment strategy for ibrutinib-resistant CLLSean D Reiff, Elizabeth M Muhowski, Daphne Guinn, et al.
Leukemia Research|August 2, 2014
A dose escalation feasibility study of lenalidomide for treatment of symptomatic, relapsed chronic lymphocytic leukemiaKami Maddocks, Amy S Ruppert, Rebekah Browning, et al.
Plos One|November 13, 2010
Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol dispositionWenjun Ni, Jia Ji, Zunyan Dai, et al.
Blood|March 31, 2010
17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibitionErin Hertlein, Amy J Wagner, Jeffrey Jones, et al.
Pageof 13